nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Quinacrine—ABCB1—peripheral nervous system neoplasm	0.00271	0.53	CrCbGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IFNB1—peripheral nervous system neoplasm	0.0027	0.0457	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—ABCB1—peripheral nervous system neoplasm	0.0024	0.47	CrCbGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IFNB1—peripheral nervous system neoplasm	0.00213	0.0361	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IFNB1—peripheral nervous system neoplasm	0.0021	0.0357	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00195	0.0331	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—PTPN11—peripheral nervous system neoplasm	0.00174	0.0295	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—PTPN11—peripheral nervous system neoplasm	0.00171	0.029	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IFNB1—peripheral nervous system neoplasm	0.00166	0.0282	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—PTPN11—peripheral nervous system neoplasm	0.00166	0.0281	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—PTPN11—peripheral nervous system neoplasm	0.00165	0.028	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PTPN11—peripheral nervous system neoplasm	0.00139	0.0235	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—PTPN11—peripheral nervous system neoplasm	0.00138	0.0233	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PTPN11—peripheral nervous system neoplasm	0.00135	0.0229	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—PTPN11—peripheral nervous system neoplasm	0.00135	0.0229	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PTPN11—peripheral nervous system neoplasm	0.00134	0.0227	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD55—peripheral nervous system neoplasm	0.00133	0.0226	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PTPN11—peripheral nervous system neoplasm	0.0013	0.0221	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PTPN11—peripheral nervous system neoplasm	0.0013	0.0221	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—PTPN11—peripheral nervous system neoplasm	0.0013	0.0221	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.00117	0.0199	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PTPN11—peripheral nervous system neoplasm	0.00108	0.0184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD55—peripheral nervous system neoplasm	0.00105	0.0179	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000972	0.0165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000926	0.0157	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—peripheral nervous system neoplasm	0.000835	0.0142	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—peripheral nervous system neoplasm	0.000812	0.0138	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—peripheral nervous system neoplasm	0.000805	0.0136	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—peripheral nervous system neoplasm	0.000784	0.0133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—peripheral nervous system neoplasm	0.000784	0.0133	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD55—peripheral nervous system neoplasm	0.000776	0.0132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000769	0.013	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000691	0.000738	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00069	0.000737	CcSEcCtD
Hydroxychloroquine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000689	0.000736	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000734	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000686	0.000733	CcSEcCtD
Hydroxychloroquine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000684	0.000731	CcSEcCtD
Hydroxychloroquine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000684	0.000731	CcSEcCtD
Hydroxychloroquine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000683	0.00073	CcSEcCtD
Hydroxychloroquine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000683	0.00073	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000682	0.000729	CcSEcCtD
Hydroxychloroquine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000681	0.000727	CcSEcCtD
Hydroxychloroquine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000675	0.000721	CcSEcCtD
Hydroxychloroquine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000675	0.000721	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000674	0.0114	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000672	0.000719	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000714	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000714	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000666	0.000712	CcSEcCtD
Hydroxychloroquine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000662	0.000708	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000661	0.000706	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000661	0.000706	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000652	0.000697	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—peripheral nervous system neoplasm	0.000651	0.011	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000651	0.000695	CcSEcCtD
Hydroxychloroquine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000647	0.000692	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000646	0.00069	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000646	0.00069	CcSEcCtD
Hydroxychloroquine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000644	0.000688	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000685	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000683	CcSEcCtD
Hydroxychloroquine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.000683	CcSEcCtD
Hydroxychloroquine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000639	0.000683	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000636	0.00068	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000632	0.000675	CcSEcCtD
Hydroxychloroquine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.000674	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000674	CcSEcCtD
Hydroxychloroquine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000629	0.000672	CcSEcCtD
Hydroxychloroquine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000627	0.00067	CcSEcCtD
Hydroxychloroquine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000626	0.000669	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.000667	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.000667	CcSEcCtD
Hydroxychloroquine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000624	0.000667	CcSEcCtD
Hydroxychloroquine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000619	0.000662	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.00066	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.00066	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000617	0.00066	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000615	0.000658	CcSEcCtD
Hydroxychloroquine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000614	0.000656	CcSEcCtD
Hydroxychloroquine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000614	0.000656	CcSEcCtD
Hydroxychloroquine—Rash—Topotecan—peripheral nervous system neoplasm	0.000614	0.000656	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD55—peripheral nervous system neoplasm	0.000614	0.0104	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000613	0.000655	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000613	0.000655	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000655	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000612	0.000654	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—peripheral nervous system neoplasm	0.000611	0.0104	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000611	0.000653	CcSEcCtD
Hydroxychloroquine—Headache—Topotecan—peripheral nervous system neoplasm	0.00061	0.000652	CcSEcCtD
Hydroxychloroquine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000609	0.000651	CcSEcCtD
Hydroxychloroquine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000609	0.000651	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000609	0.000651	CcSEcCtD
Hydroxychloroquine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000609	0.00065	CcSEcCtD
Hydroxychloroquine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000609	0.00065	CcSEcCtD
Hydroxychloroquine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000608	0.00065	CcSEcCtD
Hydroxychloroquine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000607	0.000648	CcSEcCtD
Hydroxychloroquine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000606	0.000648	CcSEcCtD
Hydroxychloroquine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000606	0.000647	CcSEcCtD
Hydroxychloroquine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000605	0.000647	CcSEcCtD
Hydroxychloroquine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000605	0.000647	CcSEcCtD
Hydroxychloroquine—Pain—Vincristine—peripheral nervous system neoplasm	0.000603	0.000645	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000602	0.000643	CcSEcCtD
Hydroxychloroquine—Rash—Melphalan—peripheral nervous system neoplasm	0.000601	0.000642	CcSEcCtD
Hydroxychloroquine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000601	0.000642	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.00064	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000636	CcSEcCtD
Hydroxychloroquine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000595	0.000635	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—peripheral nervous system neoplasm	0.000594	0.0101	CbGpPWpGaD
Hydroxychloroquine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000634	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000592	0.000633	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00059	0.01	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—peripheral nervous system neoplasm	0.000589	0.00998	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD34—peripheral nervous system neoplasm	0.000588	0.00997	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000627	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000582	0.000622	CcSEcCtD
Hydroxychloroquine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.000621	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000579	0.000618	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000579	0.000618	CcSEcCtD
Hydroxychloroquine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000578	0.000618	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000577	0.000616	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000614	CcSEcCtD
Hydroxychloroquine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000574	0.000613	CcSEcCtD
Hydroxychloroquine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000574	0.000613	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—peripheral nervous system neoplasm	0.000573	0.00972	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—peripheral nervous system neoplasm	0.000573	0.00972	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.00061	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000606	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000567	0.000605	CcSEcCtD
Hydroxychloroquine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000566	0.000605	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000566	0.0096	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00056	0.000598	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000596	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000558	0.000596	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000558	0.000596	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.000595	CcSEcCtD
Hydroxychloroquine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000555	0.000593	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000589	CcSEcCtD
Hydroxychloroquine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000545	0.000582	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.00058	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000542	0.000579	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00054	0.000577	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000539	0.000576	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000539	0.000575	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000572	CcSEcCtD
Hydroxychloroquine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000533	0.00057	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000533	0.00903	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000568	CcSEcCtD
Hydroxychloroquine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.000561	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00052	0.000555	CcSEcCtD
Hydroxychloroquine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.000553	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000551	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000549	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000545	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000508	0.000543	CcSEcCtD
Hydroxychloroquine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000506	0.000541	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000537	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000502	0.000536	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.000535	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NCAM1—peripheral nervous system neoplasm	0.0005	0.00848	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000532	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.000532	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000497	0.000531	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000529	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000493	0.000527	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000493	0.000527	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000493	0.000526	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—peripheral nervous system neoplasm	0.000489	0.000522	CcSEcCtD
Hydroxychloroquine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.000517	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000483	0.000516	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.000476	0.00808	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000508	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000504	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000469	0.000501	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000501	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000467	0.000499	CcSEcCtD
Hydroxychloroquine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000467	0.000498	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000466	0.0079	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000465	0.000497	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD34—peripheral nervous system neoplasm	0.000465	0.00788	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000497	CcSEcCtD
Hydroxychloroquine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.000493	CcSEcCtD
Hydroxychloroquine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.000493	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000492	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.00046	0.00781	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00046	0.000491	CcSEcCtD
Hydroxychloroquine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.00049	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000454	0.000485	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000484	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000452	0.000483	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000452	0.000483	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000482	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000449	0.000479	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000448	0.00759	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000448	0.000478	CcSEcCtD
Hydroxychloroquine—Rash—Vincristine—peripheral nervous system neoplasm	0.000445	0.000475	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000444	0.000475	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—peripheral nervous system neoplasm	0.000442	0.000472	CcSEcCtD
Hydroxychloroquine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.000465	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000464	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000463	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000427	0.000456	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000456	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000421	0.00045	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000421	0.00045	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000449	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000448	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000419	0.000448	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000446	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000414	0.00702	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00041	0.000438	CcSEcCtD
Hydroxychloroquine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000404	0.000432	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.00043	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000426	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000397	0.00673	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000397	0.000424	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NCAM1—peripheral nervous system neoplasm	0.000395	0.0067	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000422	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000421	CcSEcCtD
Hydroxychloroquine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000393	0.00042	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000393	0.00042	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNB1—peripheral nervous system neoplasm	0.000393	0.00665	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000419	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000391	0.000418	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000417	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000416	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000412	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000407	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.00038	0.00644	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000378	0.000404	CcSEcCtD
Hydroxychloroquine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000371	0.000396	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000395	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000394	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000391	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000364	0.00617	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000363	0.000388	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000388	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000388	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000385	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—peripheral nervous system neoplasm	0.00036	0.000385	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00036	0.000385	CcSEcCtD
Hydroxychloroquine—Headache—Etoposide—peripheral nervous system neoplasm	0.000358	0.000383	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000381	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000377	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000377	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000375	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000369	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000366	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000363	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000339	0.000363	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000359	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000357	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000355	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000349	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000347	CcSEcCtD
Hydroxychloroquine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000342	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000341	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000336	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000336	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000335	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000314	0.00532	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000332	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNB1—peripheral nervous system neoplasm	0.00031	0.00526	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000328	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000326	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HGF—peripheral nervous system neoplasm	0.000303	0.00514	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.0003	0.00509	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.0003	0.00509	CbGpPWpGaD
Hydroxychloroquine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000317	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000311	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00031	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000289	0.00491	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000308	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000304	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000302	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000298	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000296	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000295	CcSEcCtD
Hydroxychloroquine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000293	CcSEcCtD
Hydroxychloroquine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000282	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00028	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000275	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000273	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000273	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000272	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000271	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000271	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000271	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000259	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HGF—peripheral nervous system neoplasm	0.00024	0.00406	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000237	0.00402	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000252	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000252	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00025	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00025	CcSEcCtD
Hydroxychloroquine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000246	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000228	0.00387	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000242	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTPN11—peripheral nervous system neoplasm	0.000221	0.00375	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000234	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000233	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000217	0.00369	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000227	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000226	CcSEcCtD
Hydroxychloroquine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000224	CcSEcCtD
Hydroxychloroquine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000218	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000217	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000216	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000216	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000214	CcSEcCtD
Hydroxychloroquine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000209	CcSEcCtD
Hydroxychloroquine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000203	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000201	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.0002	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.0002	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000186	0.00315	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000198	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.00018	0.00306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000177	0.003	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000188	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PTPN11—peripheral nervous system neoplasm	0.000175	0.00296	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—peripheral nervous system neoplasm	0.000175	0.00296	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000167	0.00283	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000163	0.00276	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000152	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000147	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—peripheral nervous system neoplasm	0.000138	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—peripheral nervous system neoplasm	0.000133	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000132	0.00224	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000117	0.00198	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000113	0.00192	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—peripheral nervous system neoplasm	0.000105	0.00178	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000103	0.00175	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—peripheral nervous system neoplasm	9.73e-05	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.93e-05	0.00151	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—peripheral nervous system neoplasm	8.59e-05	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.11e-05	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—peripheral nervous system neoplasm	7.69e-05	0.0013	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	7.44e-05	0.00126	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	7.14e-05	0.00121	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	6.87e-05	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.79e-05	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—peripheral nervous system neoplasm	6.79e-05	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.33e-05	0.00107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.2e-05	0.000881	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.97e-05	0.000843	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	4.51e-05	0.000765	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.39e-05	0.000744	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.81e-05	0.000646	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.64e-05	0.000616	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.58e-05	0.000607	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.92e-05	0.000496	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.87e-05	0.000487	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	7.9e-06	0.000134	CbGpPWpGaD
